PCVX CIK: 1649094

Vaxcyte, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
millions USD
FY21:
0
FY22:
0
FY23:
0
FY24:
–
FY25:
–
(positive)
Change from FY21 to FY25
millions USD
FY21:
−104
FY22:
−232
FY23:
−468
FY24:
−570
FY25:
−924
(positive)
Change from FY24 to FY25
millions USD
FY21:
–
FY22:
–
FY23:
–
FY24:
−448
FY25:
−899
(positive)
Change from FY24 to FY25
millions USD
FY21:
–
FY22:
–
FY23:
–
FY24:
−464
FY25:
−767
(positive)
Change from FY21 to FY25
millions USD
FY21:
−100
FY22:
−223
FY23:
−402
FY24:
−464
FY25:
−767

All amounts in millions USD Data sources:SEC EDGARTwelve Data